COLLI, SUSANNA
 Distribuzione geografica
Continente #
EU - Europa 8.341
AS - Asia 6.346
NA - Nord America 6.014
SA - Sud America 505
AF - Africa 107
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.345
Nazione #
US - Stati Uniti d'America 5.859
GB - Regno Unito 3.176
CN - Cina 1.997
SG - Singapore 1.823
IT - Italia 1.258
SE - Svezia 890
DE - Germania 809
RU - Federazione Russa 761
HK - Hong Kong 582
TR - Turchia 429
BR - Brasile 364
VN - Vietnam 357
KR - Corea 308
FR - Francia 289
IN - India 259
NL - Olanda 252
IE - Irlanda 235
UA - Ucraina 223
BD - Bangladesh 209
FI - Finlandia 192
EU - Europa 144
CA - Canada 104
PL - Polonia 82
ID - Indonesia 72
JP - Giappone 60
PH - Filippine 59
GR - Grecia 51
IR - Iran 44
CO - Colombia 40
AR - Argentina 38
ES - Italia 34
CI - Costa d'Avorio 32
AU - Australia 25
BE - Belgio 21
EC - Ecuador 21
IQ - Iraq 20
MX - Messico 20
SA - Arabia Saudita 20
ZA - Sudafrica 17
DK - Danimarca 15
MY - Malesia 15
VE - Venezuela 14
PK - Pakistan 12
KE - Kenya 11
EG - Egitto 10
MA - Marocco 10
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
DZ - Algeria 8
IL - Israele 8
NP - Nepal 8
TH - Thailandia 8
UZ - Uzbekistan 8
PA - Panama 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
RO - Romania 6
TN - Tunisia 6
AT - Austria 5
CH - Svizzera 5
CR - Costa Rica 5
PE - Perù 5
TW - Taiwan 5
JM - Giamaica 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HU - Ungheria 3
JO - Giordania 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
Totale 21.465
Città #
Southend 3.006
Singapore 1.045
Hong Kong 560
Chandler 507
Ashburn 479
San Jose 469
Seattle 423
Milan 393
Beijing 362
Princeton 314
Wilmington 304
Dublin 234
Council Bluffs 225
Santa Clara 223
Redmond 198
Mountain View 151
Nanjing 133
Ann Arbor 132
Sakarya 132
Dallas 131
Los Angeles 127
Lauterbourg 125
Bengaluru 112
Hanover 112
Des Moines 108
Ho Chi Minh City 108
Buffalo 97
New York 96
Guangzhou 94
Dearborn 92
Fairfield 90
Jinan 89
Boardman 86
Jacksonville 86
Moscow 86
Shanghai 75
Woodbridge 72
Frankfurt am Main 71
The Dalles 71
Hanoi 70
Munich 67
Shenyang 67
Warsaw 67
Houston 59
Toronto 58
Seoul 52
Somerville 50
Tokyo 48
Andover 47
Athens 47
Serra 47
Tianjin 47
Helsinki 46
Changsha 44
Columbus 44
Grafing 44
Hebei 42
Nanchang 38
Zhengzhou 38
Jakarta 36
Bogotá 35
Redwood City 35
Bitonto 34
Eitensheim 34
Hangzhou 34
Berlin 33
Cangzhou 33
Hefei 33
Roxbury 33
Abidjan 31
São Paulo 31
Centro 30
Rome 30
Jiaxing 29
Ningbo 29
Fuzhou 26
Cambridge 25
Dong Ket 24
Phoenix 24
Taizhou 24
Turin 24
Kiez 22
Brussels 21
Nürnberg 20
Shenzhen 18
Falls Church 17
Chicago 16
Haiphong 16
Hamburg 16
Lanzhou 16
Medford 16
Mumbai 16
Orem 16
San Diego 16
Haikou 15
Kunming 15
Bangalore 14
Pisa 14
Da Nang 12
London 12
Totale 13.215
Nome #
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism 459
n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes 360
In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion 285
Effect of n-3 fatty acids on carotid atherosclerosis and hemostasis in hypertriglyceridemic patients: a double blind pilot study in primary prevention 257
Data for proteomic analysis of human monocyte-derived macrophages 247
Platelets and arachidonic acid metabolism in human and experimental hypercholesterolemia 231
Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention 229
Cytoskeletal architecture regulates cyclooxygenase-2 in human endothelial cells 229
Effect of omega-3 PUFA on carotid IMT and haemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 227
Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages 226
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 225
A mass spectrometry-based workflow for the proteomic analysis of in vitro cultured cell subsets isolated by means of laser capture microdissection 223
Cytoskeletal architecture regulates cyclooxygenase-2 in human endothelial cells : autocrine modulation by prostacyclin 220
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 220
Human monocyte-derived macrophages spontaneously differentiated in vitro show distinct phenotypes 219
Cytoskeletal architecture regulates cyclooxygenase-2 expression in human endothelial cells 218
Fatty acid composition of plasma, blood cells and whole blood : relevance for the assessment of the fatty acid status in humans 215
Mitochondrial reactive oxygen species : a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells 207
Anesthetic propofol enhances plasma gamma-tocopherol levels in patients undergoing cardiac surgery 205
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations. 205
Diversity and similarity in signaling events leading to rapid COX-2 synthesis by PMA and TNFin human endothelial cells 205
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery 203
Lipoproteine aterogene e trombosi: aspetti cellulari 203
Transglutaminase 2 modulates efferocytosis in human monocyte-derived macrophages 203
Apocynin prevents cyclooxygenase-2 expression in human monocytes through NADPH-oxidase and gluthathione redox-dependent mechanisms. 202
Cyclooxygenase-2 glycosylation is affected by peroxynitrite in endothelial cells: Impact on enzyme activity and degradation 201
Quantitative changes of hydroxyacid formation during platelet-neutrophil interaction 198
Cytoskeleton and cyclooxigenase -2 expression in human endothelial cells: autocrine modulation by prostacyclin 197
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 195
Human macrophages spontaneously differentiated in vitro are heterogeneous and show different proteomic profile 192
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 190
Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation, and plasma-free fatty acids in normal subjects 190
Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits 188
Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells 187
Macromolecular drugs II. Effects of a polymer bound nicotinic acid on experimentally induced hyperlipemia in the rat 186
Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets : role of TGF-beta1 185
Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB- and ERK2-dependent mechanisms 183
Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention 182
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 181
Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis 180
Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers 175
Phenotypic profile of lipid-enriched macrophages spontaneously differentiated from blood-derived monocytes 173
Indobufen prevents tissue factor expression in human monocytes through a thromboxane-dependent mechanism 169
Dietary interventions in north Karelia, Finland and south Italy. Modification of thromboxane B2 formation in platelets of male subjects only 169
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 169
High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli 166
Oxidized LDLs influence thrombotic response and cyclooxygenase 2 166
Albumin interferes with arachidonate metabolism in platelets and neutrophils 166
Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation : critical role of NADPH oxidase 164
Interaction of L-ascorbic acid and prostaglandins on isolated myometrium 164
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: activity on platelet aggregation and arachidonic acid metabolism 163
Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients 162
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism 160
Protease-activated receptors 1 and 2 activation induces tissue factor through mitochondrial reactive oxygen species 160
EFFETTO DEGLI ACIDI GRASSI DELLA SERIE n-3 SULL’ATEROSCLEROSI CAROTIDEA E SULL’EMOSTASI IN PAZIENTI IPERTRIGLICERIDIEMICI : STUDIO PILOTA IN DOPPIO CIECO IN PREVENZIONE PRIMARIA 159
Atherogenic lipoproteins and PAI-1 synthesis by endothelial-cells 159
Lipoproteine aterogene ed endotelio vascolare 158
Distinct phenotypes co-exist in the same culture of human monocyte-derived macrophages 158
Inhibition of cholesterol biosynthesis as a new antithrombotic strategy 157
Effect of omega-3 PUFA on carotid IMT and hemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 156
Vitamin E influences the effects of fish oil on fatty acids and eicosanoid production in plasma and circulating cells in the rat 155
15-deoxy-D12,14-prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. 154
Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-κB/IκB- and ERK2-dependent mechanisms 154
Statins in atherothrombosis 153
Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits 151
Pharmacological characterization of 2NTX-99, a potential antiatherothrombotic agent with antithromboxane and no-donor activity 150
Dietary n-9, n-6, and n-3 fatty acids modify linoleic acid more than arachidonic acid levels in plasma and platelet lipids and minimally affect platelet thromboxane formation in the rabbit 150
Cyclooxygenase-2 mediates hydrogen peroxide-induced wound repair in human endothelial cells 149
Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout 149
Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages 149
Human monocyte-derived macrophages are heterogenous : Proteomic profile of different phenotypes 148
Cyclooxygenase-2 is critical for hydrogen peroxide-mediated wound repair in human endothelial cells 147
Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis 146
Platelet function in rheumatoid arthritis 146
Control of human and animal platelet aggregation by a new prostacyclin analog 145
Effect of atherogenic lipoproteins on PAI-1 synthesis by endothelial cells 145
Atherosclerosis and thrombosis. Old and new drugs 145
Tissue factor in atherosclerosis 144
Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery 142
Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: Role of transforming growth factor-beta1 140
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: "in vitro" and "in vivo" studies 140
Vastatin inhibit tissue factor expression by human macrophages 139
Indobufen treatment in type IIA hypercholesterolemic subjects: effects on platelet function and malondialdehyde production 138
15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade 137
Antithrombotic and antiinflammatory properties of rosuvastatin in cultured human endothelial cells. 137
Vastatin inhibit tissue factor expression by human macrophages: involvement of the mevalonate pathway 137
N-Acetylcysteine Inhibits Platelet Function through the Regeneration of the Non-Oxidative Form of Albumin 136
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 136
Dipyridamole treatment in chronic obstructive airways disease: effect on platelet regeneration time 136
FARMACI ANTIAGGREGANTI PIASTRINICI 136
Antithrombotic and antiinflammatory properties of rosuvastatin in culured human endothelial cells 135
Proinflammatory lipoxygenase products from peripheral mononuclear cells in patients with rheumatoid arthritis 135
Effects of dilazep on human platelets and rat vascular tissue: in vitro studies on platelet aggregation, and arachidonic acid oxidation 134
Reactive oxygen species signal for cyclooxygenase-2 induction in human endothelial cells : role in the repair of wound 132
5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO 132
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 132
Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia 131
Endothelial tissue factor induction by T lymphocytes in systemic sclerosis 131
Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation 131
Effects of tenoxicam on superoxide anion formation, β-glucuronidase release and fMLP binding in human neutrophils : Comparison with other NSAIDs 130
Totale 17.688
Categoria #
all - tutte 55.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021617 0 0 0 0 0 0 0 0 0 0 499 118
2021/20221.620 173 79 48 146 92 134 89 66 120 164 233 276
2022/20231.898 301 211 177 218 181 383 21 117 158 22 91 18
2023/20241.005 34 99 56 62 233 62 31 79 16 61 111 161
2024/20252.494 87 263 43 279 250 100 40 316 143 219 222 532
2025/20265.533 487 221 586 411 594 468 750 348 718 459 491 0
Totale 22.612